May 10, 2024 · Authors note that tumors likely employ a variety of strategies to evade immune detection. But the discovery could lead to a new approach for targeted cancer therapies.

The present study was initiated by comparing publicly available transcription profiles of tumor tissues from responsive and resistant ICB-treated patients across various cancer types.

Oct 1, 2020 · Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell activation pathways involved in physiological immune respon…

Mar 22, 2024 · In summary, EV PD-L1 affects both immune cells and tumor cells, leading to the suppression of anti-tumor immunity and promotion of tumor progression. These processes ultimately …

Nov 13, 2025 · Tumor-associated immune checkpoints (ICPs) and their effects on mediating T cell activation. This figure illustrates the complex interplay between tumor-associated ICPs and T cell …

Jun 9, 2025 · The exploitation of immune checkpoints by cancer cells significantly impacts the anti-tumor immune response. The suppression of T-cell activation and proliferation enables cancer cells to …

Mar 13, 2025 · However, tumor cells have developed sophisticated ways to evade detection, including hijacking the immune system’s brake mechanism, known as immune checkpoints.

Discover how cancer cells bypass immune defenses and explore innovative strategies to combat the disease through scientific insights and therapeutic approaches.

Dec 16, 2025 · Even if a T-cell recognizes a cancer cell, the tumor employs a second strategy to shut down the immune attack through molecular signaling. This involves exploiting natural “brakes” in the …

Aug 15, 2024 · Cancer cells can evade immune surveillance by downregulating antigen presentation or expressing immune checkpoint molecules. High levels of tumor-infiltrating lymphocytes (TILs) …